We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Researchers from Huddersfield University say the benefits of using steroid-containing inhalers and nebulisers during the COVID-19 pandemic outweigh the risks, despite warnings to the contrary.